MEGHAN GUARINO: Open Payments
NPI 1720609969 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,528 in 60 payments from 16 companies in 2025. Trend: 2023 $179 · 2024 $1,004 · 2025 $1,528
Food & beverage: $1,528
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $420 |
| Madrigal Pharmaceuticals | 7 | $269 |
| Janssen Biotech, Inc. | 9 | $239 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $85 |
| PFIZER INC. | 4 | $82 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $81 |
| Ardelyx, Inc. | 3 | $74 |
| Intercept Pharmaceuticals, Inc. | 2 | $53 |
| Phathom Pharmaceuticals, Inc. | 2 | $42 |
| Mallinckrodt Hospital Products Inc. | 1 | $39 |
Products named: REZDIFFRA, TREMFYA, RINVOQ, LINZESS, ENTYVIO, XIFAXAN, IBSRELA, SKYRIZI.
Industry payments across FL — which companies pay providers there.
